Details

Autor(en) / Beteiligte

• Onyango, Clayton O
• Loparev, Vladimir
• Lidechi, Shirley
• Bhullar, Vinod
• Schmid, D Scott
• Radford, Kay
• Lo, Michael K
• Rota, Paul
• Johnson, Barbara W
• Munoz, Jorge
• Oneko, Martina
• Burton, Deron
• Black, Carolyn M
• Neatherlin, John
• Montgomery, Joel M
• Fields, Barry
• Carroll, Karen C.

Titel

Evaluation of a TaqMan Array Card for Detection of Central Nervous System Infections

Ist Teil von

• Journal of clinical microbiology, 2017-07, Vol.55 (7), p.2035-2044

Ort / Verlag

United States: American Society for Microbiology

Erscheinungsjahr

2017

Quelle

MEDLINE

Beschreibungen/Notizen

• Infections of the central nervous system (CNS) are often acute, with significant morbidity and mortality. Routine diagnosis of such infections is limited in developing countries and requires modern equipment in advanced laboratories that may be unavailable to a number of patients in sub-Saharan Africa. We developed a TaqMan array card (TAC) that detects multiple pathogens simultaneously from cerebrospinal fluid. The 21-pathogen CNS multiple-pathogen TAC (CNS-TAC) assay includes two parasites ( and ), six bacterial pathogens ( e, , , , , and ), and 13 viruses (parechovirus, dengue virus, Nipah virus, varicella-zoster virus, mumps virus, measles virus, lyssavirus, herpes simplex viruses 1 and 2, Epstein-Barr virus, enterovirus, cytomegalovirus, and chikungunya virus). The card also includes human RNase P as a nucleic acid extraction control and an internal manufacturer control, GAPDH (glyceraldehyde-3-phosphate dehydrogenase). This CNS-TAC assay can test up to eight samples for all 21 agents within 2.5 h following nucleic acid extraction. The assay was validated for linearity, limit of detection, sensitivity, and specificity by using either live viruses (dengue, mumps, and measles viruses) or nucleic acid material (Nipah and chikungunya viruses). Of 120 samples tested by individual real-time PCR, 35 were positive for eight different targets, whereas the CNS-TAC assay detected 37 positive samples across nine different targets. The CNS-TAC assays showed 85.6% sensitivity and 96.7% specificity. Therefore, the CNS-TAC assay may be useful for outbreak investigation and surveillance of suspected neurological disease.